An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information (Q6630315)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information |
scientific article; zbMATH DE number 7936494
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information |
scientific article; zbMATH DE number 7936494 |
Statements
An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information (English)
0 references
31 October 2024
0 references
cytokine release syndrome
0 references
dose finding
0 references
dose-toxicity curve
0 references
maximum tolerated dose
0 references
pharmacodynamics
0 references
pharmacokinetics
0 references
0 references
0 references
0 references
0 references
0 references
0 references
